Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER_GOV × Sarcoma × Clear all

Phase

Phase NA 10 Phase 2 10 Phase 4 3 Phase 1/2 2 Phase 3 1 Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 70 INDUSTRY 56 NETWORK 42 NIH 23 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 39 Gynecologic 26 Breast 19 Thoracic 14 Head & Neck 10 Other hematologic neoplasm 7 Lymphoid 6 CNS 5 Myeloid 4 Genitourinary 4 Plasma cell 3 Tumor-Agnostic 2 Other 2 Endocrine 2 Dermatologic 2 Sarcoma 1 Other solid neoplasm 1 Other neoplasm 1 NET 1 Classical hematology 1

Conditions

Sarcoma 1 Neoplasm Metastasis 1

Interventions

trametinib 1 palbociclib 1 olaparib 1 nilotinib 1 glasdegib 1 futibatinib 1 durvalumab 1 dabrafenib 1 ceritinib 1 capmatinib 1 Lapatinib 1 High-Throughput Nucleotide Sequencing 1 Base Sequence 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03784014 2025-12-11

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Active not recruiting

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡